Related Experiment Video
Updated: Feb 10, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
New pathogens, new tricks: emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics
Jennifer Geddes-McAlister1,2, Rebecca S Shapiro1
1Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
Abstract:
Fungal pathogens are a growing threat to public health. As human immunodeficiency becomes increasingly common, fungal infections are becoming more prevalent. The use of antifungal agents for prophylaxis and treatment of fungal infections has favored the emergence of previously rare or unidentified species of drug-resistant fungal pathogens, including several Candida and Cryptococcus species, as well as mold pathogens. As these new and increasingly drug-resistant fungal pathogens continue to emerge, novel strategies for rapid identification and treatment are necessary to combat these life-threatening infections.
Insights
Drug-resistant fungal pathogens pose a growing public health threat. Novel strategies are urgently needed for rapid identification and treatment of these emerging infections.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Fungal infections are increasing due to rising rates of human immunodeficiency.
- Antifungal agent use promotes the emergence of drug-resistant fungal pathogens.
- Rare and unidentified fungal species, including Candida, Cryptococcus, and molds, are becoming significant threats.
Purpose of the Study:
- To highlight the growing threat of drug-resistant fungal pathogens.
- To emphasize the need for new diagnostic and therapeutic approaches.
- To address the challenges posed by emerging fungal species.
Main Methods:
- Literature review on emerging fungal pathogens and drug resistance.
- Analysis of trends in fungal infections and antifungal use.
- Synthesis of current knowledge on identification and treatment strategies.
Main Results:
- Significant increase in prevalence of fungal infections.
- Emergence of drug-resistant strains of Candida, Cryptococcus, and molds.
- Identification of previously rare fungal species as significant pathogens.
Conclusions:
- Drug-resistant fungal pathogens represent a critical public health concern.
- Novel, rapid methods for identification and treatment are essential.
- Continued research is vital to combat life-threatening fungal infections.
Related Concept Videos
Defenses Against Pathogens and Herbivores
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors

